nucleus accumbens
Summary
The nucleus accumbens (NAc) is part of the ventral striatum and is the core of the brain's mesolimbic reward circuit. It receives dopaminergic input from the ventral tegmental area (VTA) and mediates reward, motivation, reinforcement, and addiction. Dopamine release here underlies the "wanting" of rewards and is the common final pathway for drugs of abuse.
Detail
**Anatomy** - Located in the ventral striatum, where the caudate and putamen meet, inferior to the anterior limb of the internal capsule. - Divided into a **core** (motor/limbic interface, similar to dorsal striatum) and a **shell** (linked to the extended amygdala and hypothalamus; important for the reinforcing effects of drugs). - Composed mainly of GABAergic medium spiny neurons (~95%), which express D1 (direct pathway, Gs, excitatory to the behavior) or D2 (indirect pathway, Gi, inhibitory) receptors.
**Connections (mesolimbic pathway)** - Input: dopamine from the VTA (midbrain); glutamate from the prefrontal cortex, amygdala, and hippocampus. - Output: ventral pallidum, then the mediodorsal thalamus, then the prefrontal cortex. It also projects to the hypothalamus and VTA/substantia nigra. - Mesolimbic dopamine = VTA to NAc. This is distinct from the mesocortical (VTA to PFC), nigrostriatal (SNc to dorsal striatum), and tuberoinfundibular (hypothalamus to pituitary) pathways.
**Function** - Reward processing, reinforcement learning, motivation/incentive salience ("wanting" more than "liking"), and pleasure. - Interface between limbic (emotion) and motor systems, translating motivation into action. - Reward prediction error is signaled by phasic dopamine release.
**Clinical significance** - **Substance use disorders:** Cocaine blocks DAT, and amphetamines reverse DAT and promote dopamine release. Opioids disinhibit VTA dopamine neurons (inhibit GABA interneurons via μ receptors). Nicotine stimulates VTA neurons via nicotinic receptors. Alcohol and cannabinoids also increase NAc dopamine. Chronic use leads to tolerance and downregulation of D2 receptors, with craving and relapse driven by cue-triggered activation. - **Schizophrenia:** Excess mesolimbic dopamine produces **positive symptoms** (hallucinations, delusions). D2 antagonists (antipsychotics) act here. The mesocortical pathway is hypoactive and underlies the negative symptoms. - **Depression/anhedonia:** Reduced NAc activity or reward responsiveness. - **Parkinson disease treatment:** Dopamine agonists and levodopa can cause impulse control disorders (pathologic gambling, hypersexuality, compulsive shopping) via mesolimbic overstimulation (a classic pramipexole and ropinirole adverse effect). - **Deep brain stimulation (DBS):** The NAc is a target for refractory OCD, depression, and addiction. - **Hyperprolactinemia link:** Dopamine antagonism in the tuberoinfundibular pathway, not the NAc, causes this. Do not confuse the two.
**High-yield pearls** - "Reward pathway" = VTA to NAc. - All major drugs of abuse increase dopamine in the NAc. - Mesolimbic hyperactivity = positive symptoms of schizophrenia. - NAc is part of the ventral striatum/basal ganglia limbic loop.
Sources
- First Aid for the USMLE Step 1 (Neuroanatomy, Psychiatry: Substance Use and Psychosis sections)
- Kaplan & Sadock's Synopsis of Psychiatry
- Purves et al., Neuroscience
- Kandel et al., Principles of Neural Science
- Boards & Beyond / Pathoma-style neuroscience review: Reward Pathway
Reviewed by Medusa editorial — medical student review. Information here is for study reference only and is not medical advice. Spotted an error? Let us know.